News

New research, from COMy 2025, has found that specific senescence-associated biomarkers are significantly correlated with frailty and overall survival in newly diagnosed multiple myeloma.

Interestingly, UVB exposure and topical application of cis-UCA led to changes in the skin’s microbial composition.

Largest meta-analysis shows no reduction in stroke with routine cerebral embolic protection during TAVI procedures.

Gill described the event as a “historic moment in medicine,” potentially transforming treatment options for patients.

At COMy 2025, researchers highlighted barriers to EMA-approved CAR-T cell therapy access due to age, comorbidities, and inequality.

Physiology-guided PCI halves major complications after TAVI compared to angiography alone, new FAITAVI trial data show.

A study presented at COMy 2025 found that dual MRD testing with bone marrow flow cytometry and PET/CT imaging better predicts progression-free survival in patients with multiple myeloma after autologous stem cell transplantation.

Despite therapeutic advances, delayed diagnosis of amyloid light-chain amyloidosis remains a major clinical challenge, according to data shared at the 2025 COMy Congress.